Neovacs S.A. (EPA:ALNEV)
France flag France · Delayed Price · Currency is EUR
0.0036
-0.0006 (-14.29%)
May 27, 2025, 5:35 PM CET

Neovacs Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
00----
Upgrade
Enterprise Value
-00----
Upgrade
Last Close Price
0.001.0220000.00336000.0040000.002416000.00
Upgrade
PS Ratio
0.020.35----
Upgrade
PB Ratio
0.000.01----
Upgrade
P/TBV Ratio
0.000.01----
Upgrade
EV/Sales Ratio
-0.92----
Upgrade
Debt / Equity Ratio
0.010.010.010.020.020.04
Upgrade
Asset Turnover
0.010.010.0100.000.00
Upgrade
Quick Ratio
0.620.620.992.5315.606.11
Upgrade
Current Ratio
0.650.651.032.6815.646.20
Upgrade
Return on Equity (ROE)
-98.39%-98.39%-17.66%-7.54%-43.11%-88.72%
Upgrade
Return on Assets (ROA)
-11.09%-11.09%-8.00%-7.76%-15.76%-20.63%
Upgrade
Return on Capital (ROIC)
-12.21%-12.21%-8.56%-8.37%-17.36%-30.51%
Upgrade
Earnings Yield
-441804.15%-21676.61%----
Upgrade
FCF Yield
-49408.40%-2424.17%----
Upgrade
Buyback Yield / Dilution
------327.36%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.